Ask your Database: Natural Language Processing using In-Memory Technology
|
|
|
- Hugh Park
- 10 years ago
- Views:
Transcription
1 Enterprise Platform and Integration Concepts Master Project Summer Term 2015 Ask your Database: Natural Language Processing using In-Memory Technology Dr. Mariana Neves April 10th, 2015
2 Question Answering in Biomedicine What disease is mirtazapine predominantly used for? 2
3 Question Answering in Biomedicine What disease is mirtazapine predominantly used for? major depression The 10 most commonly prescribed antidepressant drugs (citalopram hydrobromide (selective serotonin reuptake inhibitor), fluoxetine hydrochloride (selective serotonin reuptake inhibitor), amitriptyline hydrochloride (tricyclic antidepressant), dosulepin hydrochloride (tricyclic antidepressant), paroxetine hydrochloride (selective serotonin reuptake inhibitor), venlafaxine hydrochloride (other), sertraline hydrochloride (selective serotonin reuptake inhibitor), mirtazapine (other), lofepramine (tricyclic antidepressant), and escitalopram (selective serotonin reuptake inhibitor)) comprised 93.6% (n=1) of all antidepressant prescriptions. (PMID ) mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. (PMID ) "If antidepressants are used to treat insomnia, sedating ones should be preferred over activating agents such as serotonin reuptake inhibitors. In general, drugs lacking strong cholinergic activity should be preferred. Drugs blocking serotonin 5-HT2A or 5-HT2C receptors should be preferred over those whose sedative property is caused by histamine receptor blockade only. The dose should be as low as possible (e.g. as an initial dose: doxepin 25 mg, mirtazapine 15 mg, trazodone 50 mg, trimipramine 25 mg). Regarding the lack of substantial data allowing for evidence-based recommendations, we are facing a clear need for well designed, long-term, comparative studies to further define the role of antidepressants versus other agents in the management of insomnia." (PMID ) 3
4 State-of-the art 4
5 State-of-the art 5
6 State-of-the art 6
7 State-of-the art 7
8 State-of-the art 8
9 State-of-the art 9
10 Architecture of QA systems question tokenization, part-of-speech tagging, chunking syntatic parsing, named-entity recognition, document retrieval, passage retrieval, passages ranking,... question processing queries document/passage retrieval documents/passages answer processing answers, summaries 10 tokenization, part-of-speech tagging, chunking syntatic parsing, term expansion, named-entity recognition,... answer extraction, summarization, answer validation...
11 QA architecture in IMDB What disease is mirtazapine predominantly used for? in-memory database domain knowledge question processing document/ passage retrieval answer processing Answer: major depression Summary: Mirtazapine is predominantly used in the treatment of major depression. Passages: second-generation antidepressants (selective serotonin reuptake inhibitors, nefazodone, venlafaxine, and mirtazapine) in participants younger than 19 years with MDD, OCD, or non-ocd anxiety disorders. (PMID ) 11
12 NLP in SAP HANA 12 Built-in features Support to many languages Document indexing Fuzzy search Sentence splitting, tokenization, part-of-speech tagging Named entity recognition (dictionaries and/or rules) Sentiments, negations(?), speculations(?)
13 Our QA prototype 13 supplementary-material-for-the-manuscript-in-memory-database-for-passage-retrieval-in-biomedical-question-answering
14 Our QA prototype 14
15 question processing Sentence splitting What disease is mirtazapine predominantly used for? Tokenization What disease is mirtazapine predominantly used for Part-of-speech tagging What/WP disease/nn is/vbz mirtazapine/nn predominantly/rb... Chunking [What disease]np [is]vp [mirtazapine]np [predominantly used]vp Entity recognition mirtazapine/chemical_chebi:6950 Term expansion disease [disorder; syndrome] Semantic role labeling treat(agent:mirtazapine; theme:disease) Expected answer [DISEASE] Question type factoid Query construction disease [disorder; syndrome] AND mirtazapine [remeron]... (Analysis powered by Stanford parser, Genia tagger, becas, BioPortal) mirtazapine [remeron]...
16 document/passage retrieval Sentence splitting mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) Tokenization METHODS : Antidepressant therapy with 15 to 45 mg / d of. Part-of-speech tagging Patients/NNS 65/CD years/nns or/cc older/jjr with/in... Chunking [patients 65 years]np or [older]adjp [with]pp [major depression]np Entity recognition major depression/disorder_snomedct: mirtazapine/chemical_chebi:6950 gastric/fma:stomach Semantic role labeling treat (agent:mirtazapine; theme: depression) Passage retrieval METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) Passages ranking (0.8) METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) (0.5) mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. (Analysis powered by Stanford parser, Genia tagger and becas)
17 answer processing Answer extraction Summarization SRL-Question: treat(agent:mirtazapine; theme:disease) SRL-Passage: treat (agent:mirtazapine; theme: depression) Expected answer: [disease] NER: major depression/disorder_snomedct: major depression - Mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. - METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) Antidepressant therapy with mirtazapine will make it the first-choice drug in depressive patients Answer validation 17 - major depression - Antidepressant therapy with mirtazapine will make it the first-choice drug in depressive patients (Analysis powered by Google)
18 Master project Ask your Database 18 Goals Implement new NLP functionalities in SAP HANA database Adapt current NLP features in SAP HANA to the biomedical domain Participate in the development of a QA system for the biomedical domain Evaluate the application on the BioASQ dataset
19 Master project Ask your Database 19 Groups Natural Language Processing in IMDB (3 students) Question Answering for Biomedicine (6 students)
20 Group 1-NLP: Natural Language Processing in IMDB What disease is mirtazapine predominantly used for? Tokenization What disease is mirtazapine predominantly used for Part-of-speech tagging What/WP disease/nn is/vbz mirtazapine/nn predominantly/rb... Chunking [What disease]np [is]vp [mirtazapine]np [predominantly used]vp Semantic role labeling treat(agent:mirtazapine; theme:disease) 20
21 Group 1-NLP: Natural Language Processing in IMDB 21 Tokenization, Part-of-speech tagging, Chunking, Semantic role labeling Supervised learning (Support Vector Machines): Predictive Analysis Library (R, C++) Corpora: GENIA, TweetNLP, CoNLL-2000, CoNLL-2005, BioProp Integration into HANA full text indexing
22 Group 2 - QA: Question Answering for Biomedicine QA-1: Question processing What disease is mirtazapine predominantly used for? 22 Expected answer [DISEASE] Question type factoid Query construction disease [disorder; syndrome] AND mirtazapine [remeron]...
23 Group 2 - QA: Question Answering for Biomedicine QA-1: Question processing Output from the NLP group SQL, stored procedures 23 query construction, question type and target recognition Supervised learning (Support Vector Machines): Predictive Analysis Library (R, C++) Corpus: BioASQ
24 Group 2 - QA: Question Answering for Biomedicine QA-2: Named-entity recognition What disease is mirtazapine predominantly used for? Entity recognition mirtazapine/chemical_chebi:6950 mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) Entity recognition 24 major depression/disorder_snomedct: mirtazapine/chemical_chebi:6950 gastric/fma:stomach
25 Group 2 - QA: Question Answering for Biomedicine 25 QA-2: Named-entity recognition integration of various resources HANA's built-in NER features Corpus/evaluation: various + BioASQ
26 Group 2 - QA: Question Answering for Biomedicine QA-3: Passage retrieval Passage retrieval Passages ranking 26 METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) (0.8) METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) (0.5) mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers.
27 Group 2 - QA: Question Answering for Biomedicine 27 QA-3: Passage retrieval Ranking passages/sentences Calculate a score PubMed indexed in Future SOC lab Output from NLP and NER groups SQL, stored procedures Evaluation: BioASQ
28 Group 2 - QA: Question Answering for Biomedicine QA-4: Answer processing Answer extraction 28 SRL-Question: treat(agent:mirtazapine; theme:disease) SRL-Passage: treat (agent:mirtazapine; theme: depression) Expected answer: [disease] NER: major depression/disorder_snomedct: major depression
29 Group 2 - QA: Question Answering for Biomedicine 29 QA-4: Answer processing Answers for factoid/list/yes-no questions Output from NER and NLP groups SQL, stored procedures Evaluation: BioASQ
30 Group 2 - QA: Question Answering for Biomedicine 30 QA-4: Answer processing Answers for factoid/list/yes-no questions Output from NER and NLP groups SQL, stored procedures Evaluation: BioASQ
31 Group 2 - QA: Question Answering for Biomedicine QA-5: Summarization Summarization - Mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers. - METHODS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122) Antidepressant therapy with mirtazapine will make it the first-choice drug in depressive patients 31
32 Group 2 - QA: Question Answering for Biomedicine 32 QA-5: Summarization Answers for summary questions SQL, stored procedures Evaluation: BioASQ
33 Demo Web tool 33 Input: question Output: Answers (exact + summary) Relevant passages (highlighted entities) Feedback from users
34 Master project Ask your Database 34 Grading Report/paper: 40% Commitment: 10% Implementation: 50%
35 Master project Ask your Database 35 Web page: ject2015.html Room: Campus D, E Mail with 3 top choices to [email protected] until Mon, April 13th Meeting every 2 weeks (Mariana/Cindy) Mid-term presenation (June) and final presentation (July)
36 Master project Ask your Database 36 Contact: Villa, HPI Campus II, room V1.02 Dr. Mariana Neves Cindy Fähnrich, Msc. Dr. Matthias Uflacker
37 Master project Ask your Database 37 Mail with 3 top choices to [email protected] until Mon, April 13th NLP: Natural Language Processing in IMDB QA-1: Question processing QA-2: Named-entity recognition QA-3: Passage retrieval QA-4: Answer processing QA-5: Summarization
HPI in-memory-based database system in Task 2b of BioASQ
CLEF 2014 Conference and Labs of the Evaluation Forum BioASQ workshop HPI in-memory-based database system in Task 2b of BioASQ Mariana Neves September 16th, 2014 Outline 2 Overview of participation Architecture
Medicines for Treating Depression. A Review of the Research for Adults
Medicines for Treating Depression A Review of the Research for Adults Is This Information Right for Me? Yes, if: A doctor or other health care professional has told you that you have depression. Your doctor
What are the best treatments?
What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,
POPULAR DEPRESSION MEDICATIONS
Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant
ANTIDEPRESSANT MEDICINES. A GUIDE for ADULTS With DEPRESSION
ANTIDEPRESSANT MEDICINES A GUIDE for ADULTS With DEPRESSION August 2007 FAST FACTS ON ANTIDEPRESSANTS The antidepressants in this guide work for treating depression. Most people can find one that makes
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
Antidepressants and suicidal thoughts and behaviour. Pharmacovigilance Working Party. January 2008
Antidepressants and suicidal thoughts and behaviour Pharmacovigilance Working Party January 2008 PhVWP PAR January 2008 Page 1/15 1. Introduction The Pharmacovigilance Working Party has on a number of
Recognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
Clinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD 20850 www.mamsi.com
Clinical Practice Guideline: Depression in 4 Taft Court Rockville, MD 20850 www.mamsi.com 40 05 17 035 3/03 Once a primary care patient presents with depressive symptoms, the primary care physician makes
1. Which of the following SSRIs requires up to a 5-week washout period because of the
1 Chapter 38. Major Depressive Disorders, Self-Assessment Questions 1. Which of the following SSRIs requires up to a 5-week washout period because of the long half-life of its potent active metabolite?
Depression. Medicines To Help You
Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available
Member Rights & Responsibilities
Member Rights & Responsibilities Member Rights and Responsibilities Blue KC has updated our Member Rights & Responsibilities to be consistent across all of our HMO and PPO products. Blue KC members have:
A Framework-based Online Question Answering System. Oliver Scheuer, Dan Shen, Dietrich Klakow
A Framework-based Online Question Answering System Oliver Scheuer, Dan Shen, Dietrich Klakow Outline General Structure for Online QA System Problems in General Structure Framework-based Online QA system
Architecture of an Ontology-Based Domain- Specific Natural Language Question Answering System
Architecture of an Ontology-Based Domain- Specific Natural Language Question Answering System Athira P. M., Sreeja M. and P. C. Reghuraj Department of Computer Science and Engineering, Government Engineering
NICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
Depression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
Why are antidepressants used to treat IBS? Some medicines can have more than one action (benefit) in treating medical problems.
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD What are functional GI disorders? There are more
TREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
Selective serotonin re-uptake inhibitors in child and adolescent depression
Galantamine (Reminyl) Selective serotonin re-uptake inhibitors in child and adolescent depression Summary The Therapeutic Goods Administration has issued warnings about risks of using selective serotonin
Natural Language Processing in the EHR Lifecycle
Insight Driven Health Natural Language Processing in the EHR Lifecycle Cecil O. Lynch, MD, MS [email protected] Health & Public Service Outline Medical Data Landscape Value Proposition of NLP
Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence
Pharmacotherapy of BPSD Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence Pharmacological interventions Reducing medication errors. Reducing potentially inappropriate medication prescription.
Workshop: Management of Depression in the Primary Care Setting, Kaiser Permanente of Ohio s Multidisciplinary Model
Workshop: Management of Depression in the Primary Care Setting, Kaiser Permanente of Ohio s Multidisciplinary Model Larissa Elgudin, MD, Chief of Behavioral Health Services Colleen O Malley RN, BSN, Regional
12629 LIBRIUM CHLORDIAZEPOXIDE HCL 12637 LIBRIUM CHLORDIAZEPOXIDE HCL 12645 LIBRIUM CHLORDIAZEPOXIDE HCL 13110 VALIUM DIAZEPAM 13277 VALIUM DIAZEPAM 24406 LITHANE LITHIUM CARBONATE 25836 SURMONTIL TRIMIPRAMINE
Survey Results: Requirements and Use Cases for Linguistic Linked Data
Survey Results: Requirements and Use Cases for Linguistic Linked Data 1 Introduction This survey was conducted by the FP7 Project LIDER (http://www.lider-project.eu/) as input into the W3C Community Group
If you are not clear about why an antidepressant has been suggested for you, ask your doctor.
Antidepressants Aims of the leaflet This leaflet is for anyone who wants to know more about antidepressants. It discusses how they work, why they are prescribed, their effects and side-effects, and alternative
TREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
Antidepressant treatment in adults
Antidepressant treatment in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive and
PPInterFinder A Web Server for Mining Human Protein Protein Interaction
PPInterFinder A Web Server for Mining Human Protein Protein Interaction Kalpana Raja, Suresh Subramani, Jeyakumar Natarajan Data Mining and Text Mining Laboratory, Department of Bioinformatics, Bharathiar
Depression: management of depression in primary and secondary care
Issue date: December 2004 Quick reference guide Depression: management of depression in primary and secondary care Clinical Guideline 23 Developed by the National Collaborating Centre for Mental Health
Amendments to recommendations concerning venlafaxine
Amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine*. This amendment brings the guideline into line with the new advice but does
The Antidepressants: Treating Depression. Comparing Effectiveness, Safety, and Price
The Antidepressants: Treating Depression Comparing Effectiveness, Safety, and Price Our Recommendations Antidepressants can improve the symptoms of depression, but they can also have serious side effects.
Depressive disorders among older residents in a Chinese rural community. Risk for Depression by Age and Sex. Risk for Depression by Age and Sex
Risk for Depression by Age and Sex Risk for Depression by Age and Sex Depressive disorders among older residents in a Chinese rural community. Liu CY, et al: Psychological Medicine 1997:27: 943-949 Male
Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.
Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review
MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families
MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families David A. Kahn, MD, Margaret L. Moline, PhD, Ruth W. Ross, MA, Lee S. Cohen, MD, and Lori L. Altshuler, MD www.womensmentalhealth.org
find out about... tricyclic antidepressants a publication from
find out about... tricyclic antidepressants a publication from Why have I been prescribed this drug? Tricyclic and related Antidepressants (TCAs) are prescribed for people suffering from depression or
Depression in adults with a chronic physical health problem
Depression in adults with a chronic physical health problem Treatment and management Issued: October 2009 NICE clinical guideline 91 guidance.nice.org.uk/cg91 NICE has accredited the process used by the
Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women
Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women Irina Shestakova, MD, PhD Research Center of Obstetrics, Gynecology and Perinatology Department of
Major Depression. What is major depression?
Major Depression What is major depression? Major depression is a serious medical illness affecting 9.9 million American adults, or approximately 5 percent of the adult population in a given year. Unlike
and body dysmorphic disorder (BDD) in adults, children and young people Issue date: November 2005
Issue date: November 2005 Treating obsessivecompulsive disorder (OCD) and body dysmorphic disorder (BDD) in adults, children and young people Understanding NICE guidance information for people with OCD
The Pharmacological Management of Depression in the Adult Person with Mental Retardation and Developmental Disabilities (MR/DD)
The Pharmacological Management of Depression in the Adult Person with Mental Retardation and (MR/DD) 1. Overview Multiple classes of medications are available for treatment of depression in the patient
Automatic Knowledge Base Construction Systems. Dr. Daisy Zhe Wang CISE Department University of Florida September 3th 2014
Automatic Knowledge Base Construction Systems Dr. Daisy Zhe Wang CISE Department University of Florida September 3th 2014 1 Text Contains Knowledge 2 Text Contains Automatically Extractable Knowledge 3
An Investigation of Atypical Antidepressants
An Investigation of Atypical Antidepressants An Interactive Qualifying Project Report submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE in partial fulfillment of the requirements for the Degree
Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD)
Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD) Overview of Prescription The DD/MR patient may develop symptoms
Ninety-three cases of alcohol dependence following SSRI treatment
International Journal of Risk & Safety in Medicine 26 (2014) 99 107 DOI 10.3233/JRS-140616 IOS Press 99 Ninety-three cases of alcohol dependence following SSRI treatment Louise Brookwell a, Carys Hogan
Search and Information Retrieval
Search and Information Retrieval Search on the Web 1 is a daily activity for many people throughout the world Search and communication are most popular uses of the computer Applications involving search
Overview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
TITLE: Cannabinoids for the Treatment of Post-Traumatic Stress Disorder: A Review of the Clinical Effectiveness and Guidelines
TITLE: Cannabinoids for the Treatment of Post-Traumatic Stress Disorder: A Review of the Clinical Effectiveness and Guidelines DATE: 01 December 2009 CONTEXT AND POLICY ISSUES: Post-traumatic stress disorder
Measuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center
Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):
Remeron (mirtazapine)
Remeron (mirtazapine) FDA ALERT [07/2005] Suicidal Thoughts or Actions in Children and Adults Patients with depression or other mental illnesses often think about or attempt suicide. Closely watch anyone
Potential Savings from Generic Drugs in Upstate New York
T H E F A C T S A B O U T Potential Savings from Generic Drugs in Upstate New York $880 Million in Potential Savings for Upstate New York Counties Finger Lakes Region $141 million Western New York Region
POSBIOTM-NER: A Machine Learning Approach for. Bio-Named Entity Recognition
POSBIOTM-NER: A Machine Learning Approach for Bio-Named Entity Recognition Yu Song, Eunji Yi, Eunju Kim, Gary Geunbae Lee, Department of CSE, POSTECH, Pohang, Korea 790-784 Soo-Jun Park Bioinformatics
31 Case Studies: Java Natural Language Tools Available on the Web
31 Case Studies: Java Natural Language Tools Available on the Web Chapter Objectives Chapter Contents This chapter provides a number of sources for open source and free atural language understanding software
Drug Class Review Drugs for Fibromyalgia
Drug Class Review Drugs for Fibromyalgia Final Original Report April 2011 The Agency for Healthcare Research and Quality has not yet seen or approved this report. The purpose of the is to summarize key
Depression. Using Antidepressants to Treat. Contents. 2: Our Recommendations. 3: Welcome. 5: What Are Antidepresssants and Who Needs Them?
Using Antidepressants to Treat Depression Comparing Effectiveness, Safety, and Price Contents 2: Our Recommendations 3: Welcome 5: What Are Antidepresssants and Who Needs Them? 9: Choosing an Antidepresssant
CNS prescription drugs and their ability to impair, y. Antidepressants. Indications for the existence of behavioral toxicity of antidepressants
CNS prescription drugs and their ability to impair, y FACTA 1 JG Ramaekers, Dept Neuropsychology & Psychopharmacology Maastricht University, The Netherlands ([email protected]) TCAs RIMAs
Treating Major Depressive Disorder
Treating Major Depressive Disorder A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition, originally published in October 2010.
Automatic Text Analysis Using Drupal
Automatic Text Analysis Using Drupal By Herman Chai Computer Engineering California Polytechnic State University, San Luis Obispo Advised by Dr. Foaad Khosmood June 14, 2013 Abstract Natural language processing
How To Treat A Heart Attack With Depression
W. Grady Carter M.D. Community Associate Professor of Psychiatry and Behavioral Science Mercer University School of Medicine Depressed Patients in Primary Care? What percentage of antidepressant prescriptions
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic
Practice guideline for the treatment of patients with major depressive disorder.
GUIDELINE TITLE Practice guideline for the treatment of patients with major depressive disorder. BIBLIOGRAPHIC SOURCE(S) American Psychiatric Association practice guideline for the treatment of patients
How to Identify and Diagnose Depression
Depression Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 Depression and MS Date of issue: March 2010 Review date: March 2011 Contents Introduction 2 1.
Objectives. Depression and Anxiety: Latest in treatment recommendations. At the conclusion of this presentation the attendee will be able to:
Depression and Anxiety: Latest in treatment recommendations Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC President, Fitzgerald Health Education Associates, Inc., North Andover, MA Family
A Pilot Study of the Incidence of Exposure to Drugs for which Preemptive Pharmacogenomic Testing Is Available
A Pilot Study of the Incidence of Exposure to Drugs for which Preemptive Pharmacogenomic Testing Is Available Richard D. Boyce 1 Kathrin Blagec 2 Matthias Samwald 2 1 Department of Biomedical Informatics,
Anxiety Disorders Drug Treatment Guidelines
Western Australian Psychotropic Drugs Committee Anxiety Disorders Drug Treatment Guidelines August 2008 www.watag.org.au Table of Contents Executive Summary... 4 Psychological or pharmacological treatment?...
1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care
PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When
making sense of antidepressants making sense antidepressants
making sense of antidepressants making sense antidepressants Making sense of antidepressants This booklet is for anyone who wants to know more about antidepressants. It explains what antidepressants are,
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:
Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through
CENG 734 Advanced Topics in Bioinformatics
CENG 734 Advanced Topics in Bioinformatics Week 9 Text Mining for Bioinformatics: BioCreative II.5 Fall 2010-2011 Quiz #7 1. Draw the decompressed graph for the following graph summary 2. Describe the
Protein-protein Interaction Passage Extraction Using the Interaction Pattern Kernel Approach for the BioCreative 2015 BioC Track
Protein-protein Interaction Passage Extraction Using the Interaction Pattern Kernel Approach for the BioCreative 2015 BioC Track Yung-Chun Chang 1,2, Yu-Chen Su 3, Chun-Han Chu 1, Chien Chin Chen 2 and
Schema documentation for types1.2.xsd
Generated with oxygen XML Editor Take care of the environment, print only if necessary! 8 february 2011 Table of Contents : ""...........................................................................................................
SECTION M BEHAVIORAL HEALTH SERVICES
Phoenix Health Plan s (PHP) goal for its members is to ensure that behavioral health services are readily available for Title XIX (Medicaid) and the Title XXI (KidsCare) members. Comprehensive behavioral
Treatment and management of depression in adults, including adults with a chronic physical health problem
Issue date: October 2009 Depression Treatment and management of depression in adults, including adults with a chronic physical health problem This is an update of NICE clinical guideline 23 Developed by
Depre r s e sio i n o i n i a dults Yousuf Al Farsi
Depression in adults Yousuf Al Farsi Objectives 1. Aetiology 2. Classification 3. Major depression 4. Screening 5. Differential diagnosis 6. Treatment approach 7. When to refer 8. Complication 9. Prognosis
SESSION K2. When SSRIs Are Not Enough, What Then?
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 SESSION K2 3:55 When SSRIs Are Not Enough, What Then? Scott MacHaffie, MN, ARNP S E S S I O N Session Description:
